Clinical Trial Update: Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in non-small cell lung cancer with brain metastases is currently recruiting, evaluating an immune therapy in combination with precision…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Snippet

Sponsor: Hunan Province Tumor Hospital | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: RECRUITING